Literature DB >> 17270306

Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis.

Xue-Ming Wu1, Hiroaki Todo, Kenji Sugibayashi.   

Abstract

A combination of microneedle pretreatment and iontophoresis was evaluated for the potential to increase skin permeation of drugs. Two model compounds with low and high molecular D(2)O and fluorescein isothiocyanate (FITC)-dextrans (FD-4, FD-10, FD-40, FD-70 and FD-2000; average molecular weight of 3.8, 10.1, 39.0, 71.2 and 200.0 kDa), respectively, were used and the effect of microneedle pretreatment and iontophoresis on their in vitro permeability was evaluated using excised hairless rat skin with a 2-chamber diffusion cell. Convective solvent flow through the skin was measured using a set of calibrated capillaries attached to the diffusion cell. The following results were obtained: (1) convective solvent flow (electroosmosis) during iontophoresis through microneedle-pretreated skin, 2.62+/-0.32 microL/cm(2)/h, was almost the same as through intact skin, 2.71+/-0.25 microL/cm(2)/h, and (2) the combination of microneedle pretreatment and subsequent iontophoresis significantly enhanced FD flux compared with microneedle pretreatment alone or iontophoresis alone, whereas no synergistic effect was found on the flux of D(2)O. These results suggest that the combination of iontophoresis with microneedle pretreatment may be a useful means to increase skin permeation of high molecular compounds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17270306     DOI: 10.1016/j.jconrel.2006.12.017

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

Review 1.  Transdermal delivery of proteins.

Authors:  Haripriya Kalluri; Ajay K Banga
Journal:  AAPS PharmSciTech       Date:  2011-03-03       Impact factor: 3.246

2.  Enhanced topical delivery of small hydrophilic or lipophilic active agents and epidermal growth factor by fractional radiofrequency microporation.

Authors:  Jaekwan Kim; Ji-Hye Jang; Ji Hae Lee; Jin Kyu Choi; Woo-Ram Park; Il-Hong Bae; Joonho Bae; Jin Woo Park
Journal:  Pharm Res       Date:  2012-03-08       Impact factor: 4.200

3.  Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.

Authors:  Punit P Shah; Pinaki R Desai; Mandip Singh
Journal:  J Control Release       Date:  2011-11-21       Impact factor: 9.776

Review 4.  Advances in transdermal insulin delivery.

Authors:  Yuqi Zhang; Jicheng Yu; Anna R Kahkoska; Jinqiang Wang; John B Buse; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-12-08       Impact factor: 15.470

5.  Analysis of Mechanical Failure of Polymer Microneedles by Axial Force.

Authors:  Jung-Hwan Park; Mark R Prausnitz
Journal:  J Korean Phys Soc       Date:  2010-04       Impact factor: 0.649

Review 6.  Microneedle-based vaccines.

Authors:  Mark R Prausnitz; John A Mikszta; Michel Cormier; Alexander K Andrianov
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

7.  Flux of ionic dyes across microneedle-treated skin: effect of molecular characteristics.

Authors:  Yasmine A Gomaa; Martin J Garland; Fiona J McInnes; Ryan F Donnelly; Labiba K El-Khordagui; Clive G Wilson
Journal:  Int J Pharm       Date:  2012-08-30       Impact factor: 5.875

8.  Microporation and 'iron'tophoresis for treating iron deficiency anemia.

Authors:  Naresh Modepalli; Seongbong Jo; Michael A Repka; S Narasimha Murthy
Journal:  Pharm Res       Date:  2012-11-28       Impact factor: 4.200

Review 9.  Microneedles for drug and vaccine delivery.

Authors:  Yeu-Chun Kim; Jung-Hwan Park; Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2012-05-01       Impact factor: 15.470

Review 10.  Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety.

Authors:  Ryan F Donnelly; Thakur Raghu Raj Singh; A David Woolfson
Journal:  Drug Deliv       Date:  2010-05       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.